MATERIALS AND METHODS FOR TREATING PTEN MUTATED OR DEFICIENT CANCER

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20140378525A1
SERIAL NO

14125185

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The use of inhibitors of mitotic kinases, such as TTK protein kinase, is described for use in the treatment of cancers which are characterized as Phosphatase and Tensin Homolog (PTEN) mutated or deficient cancers.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE INSTITUTE OF CANCER RESEARCH ROYAL CANCER HOSPITAL123 OLD BROMPTON ROAD LONDON SW7 3RP

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ashworth, Alan London, GB 25 251
Brough, Rachel London, GB 1 0
Frankum, Jessica London, GB 1 0
Lord, Christopher James London, GB 6 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation